Grown Rogue International (GRUSF) Shares Outstanding (Diluted Average) (2010 - 2025)
Grown Rogue International (GRUSF) recorded quarterly Shares Outstanding (Diluted Average) of $255.6 million in Q3 2025, little changed quarter-over-quarter from $256.5 million in Q2 2025, and up 39.53% on a YoY basis from $183.1 million in Q3 2024.
Grown Rogue International (GRUSF) Shares Outstanding (Diluted Average) (2010 - 2025) Analysis & Trends
Grown Rogue International's Shares Outstanding (Diluted Average) history runs 12 years deep, the most recent figure standing at $255.6 million for Q3 2025.
- In Q3 2025, Shares Outstanding (Diluted Average) rose 39.53% year-over-year to $255.6 million; the TTM figure through Sep 2025 stood at $255.6 million (up 39.53% YoY), while the FY2024 annual figure was $237.4 million, up 10.92% from the prior year.
- Shares Outstanding (Diluted Average) was $255.6 million for Q3 2025 at Grown Rogue International, roughly flat from $256.5 million in the prior quarter.
- In the past five years, Shares Outstanding (Diluted Average) ranged from a high of $256.5 million in Q2 2025 to a low of $135.2 million in Q4 2021.
- Historically, Shares Outstanding (Diluted Average) has averaged $203.5 million across 5 years, with a median of $198.6 million in 2023.
- The sharpest annual moves came in 2023 and 2025: Shares Outstanding (Diluted Average) increased 5.46% in 2023, then jumped 43.95% in 2025.
- A 5-year view of Shares Outstanding (Diluted Average) shows it stood at $135.2 million in 2021, then rose by 25.11% to $169.2 million in 2022, then climbed by 26.51% to $214.0 million in 2023, then advanced by 10.92% to $237.4 million in 2024, then increased by 7.63% to $255.6 million in 2025.
- The last three Shares Outstanding (Diluted Average) figures came in at $255.6 million (Q3 2025), $256.5 million (Q2 2025), and $249.2 million (Q1 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares (Diluted Avg.) (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 38.34 Bn | 34.60 Bn | 1.97 Bn | 1.18 Bn |
| 2 | Zoetis | 33.27 Bn | 31.33 Bn | 1.62 Bn | 422.40 Mn |
| 3 | United Therapeutics | 23.75 Bn | 21.60 Bn | 648.10 Mn | 47.20 Mn |
| 4 | Aurora Cannabis | 17.11 Bn | 17.03 Bn | 33.43 Mn | - |
| 5 | Neurocrine Biosciences | 16.37 Bn | 15.05 Bn | 800.70 Mn | 103.40 Mn |
| 6 | Elanco Animal Health | 11.78 Bn | 11.35 Bn | 785.00 Mn | 506.00 Mn |
| 7 | Alkermes | 7.05 Bn | 6.54 Bn | -116.06 Mn | - |
| 8 | Lantheus Holdings | 6.49 Bn | 5.99 Bn | 230.92 Mn | - |
| 9 | Hims & Hers Health | 6.19 Bn | 5.44 Bn | 396.79 Mn | 228.36 Mn |
| 10 | Grown Rogue International | - | - | 3.96 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | 255.55 Mn |
| Jun 30, 2025 | 256.53 Mn |
| Mar 31, 2025 | 249.24 Mn |
| Dec 31, 2024 | 237.43 Mn |
| Sep 30, 2024 | 183.15 Mn |
| Jun 30, 2024 | 178.21 Mn |
| Mar 31, 2024 | 214.05 Mn |
| Dec 31, 2023 | 214.05 Mn |
| Oct 31, 2023 | 178.43 Mn |
| Jul 31, 2023 | 170.83 Mn |
| Oct 31, 2022 | 169.19 Mn |
| Oct 31, 2021 | 135.23 Mn |
| Aug 31, 2017 | 2.07 Bn |
| May 31, 2017 | 2.67 Bn |
| Feb 28, 2017 | 27.19 Bn |
| Nov 30, 2016 | 27.18 Bn |
| Aug 31, 2016 | 1.60 Bn |
| May 31, 2016 | 16.91 |
| Feb 29, 2016 | 14.41 |
| Nov 30, 2015 | 1,444.76 |